Simplex Trading
NBRV

Simplex Trading’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Simplex Trading’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28
Closed – – 11531
2022
Q2 		$0 Buy
28
+19
+211% +$124 ﹤0.01% 11754
2022
Q1 		$0 Sell
9
-683
-99% -$8.3K ﹤0.01% 11986
2021
Q4 		$10K Buy
+692
New +$16.4K ﹤0.01% 9090
2021
Q1 		– Sell
-186
Closed -$11.6K – 10623
2020
Q4 		$11K Buy
+186
New +$20.2K ﹤0.01% 7381
2020
Q2 		– Sell
-51
Closed -$8.51K – 8741
2020
Q1 		$7K Sell
51
-25
-33% -$7.65K ﹤0.01% 6720
2019
Q4 		$24K Buy
+76
New +$34.9K ﹤0.01% 5827
2019
Q3 		– Sell
-31
Closed -$17.5K – 8201
2019
Q2 		$18K Sell
31
-37
-54% -$22.7K ﹤0.01% 5717
2019
Q1 		$41K Buy
+68
New +$37.1K ﹤0.01% 5178
2018
Q4 		– Sell
-122
Closed -$82K – 8206
2018
Q3 		$82K Buy
122
+98
+408% +$69.5K ﹤0.01% 4645
2018
Q2 		$20K Buy
24
+23
+2,300% +$26.3K ﹤0.01% 5874
2018
Q1 		$1K Buy
+1
New +$1.48K ﹤0.01% 5915

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's NBRV Position: Q3 2022 in Review

Simplex Trading sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2022, closing a stake of 28 shares.

Simplex Trading first reported a position in NBRV in Q1 2018 and held it in 11 quarters. The position peaked at $82K in Q3 2018. 13 funds tracked by Wall St. Rank hold NBRV as of Q3 2022.

  • Simplex Trading reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 28 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2022.
  • Simplex Trading first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q1 2018 and held it in 11 quarters.
  • Simplex Trading's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $82K in Q3 2018.
  • 13 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.